| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial.
|
Eur Heart J
|
2006
|
4.69
|
|
2
|
Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis.
|
Circulation
|
2003
|
2.59
|
|
3
|
Circulating CD31+/Annexin V+ microparticles correlate with cardiovascular outcomes.
|
Eur Heart J
|
2010
|
2.12
|
|
4
|
Risk and fate of cerebral embolism after transfemoral aortic valve implantation: a prospective pilot study with diffusion-weighted magnetic resonance imaging.
|
J Am Coll Cardiol
|
2010
|
1.98
|
|
5
|
Endothelial microparticle-mediated transfer of MicroRNA-126 promotes vascular endothelial cell repair via SPRED1 and is abrogated in glucose-damaged endothelial microparticles.
|
Circulation
|
2013
|
1.72
|
|
6
|
Angiotensin II impairs endothelial progenitor cell number and function in vitro and in vivo: implications for vascular regeneration.
|
Hypertension
|
2011
|
1.68
|
|
7
|
CD34-/CD133+/VEGFR-2+ endothelial progenitor cell subpopulation with potent vasoregenerative capacities.
|
Circ Res
|
2006
|
1.67
|
|
8
|
In vitro differentiation characteristics of cultured human mononuclear cells-implications for endothelial progenitor cell biology.
|
Biochem Biophys Res Commun
|
2005
|
1.65
|
|
9
|
Systemic inflammatory response syndrome predicts increased mortality in patients after transcatheter aortic valve implantation.
|
Eur Heart J
|
2012
|
1.62
|
|
10
|
Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation.
|
Circulation
|
2003
|
1.61
|
|
11
|
Methods for evaluating endothelial function: a position statement from the European Society of Cardiology Working Group on Peripheral Circulation.
|
Eur J Cardiovasc Prev Rehabil
|
2011
|
1.55
|
|
12
|
Circulating endothelial progenitor cells correlate with erectile function in patients with coronary heart disease.
|
Eur Heart J
|
2006
|
1.53
|
|
13
|
Estrogen-stimulated endothelial repair requires osteopontin.
|
Arterioscler Thromb Vasc Biol
|
2008
|
1.50
|
|
14
|
Cognitive trajectory after transcatheter aortic valve implantation.
|
Circ Cardiovasc Interv
|
2013
|
1.44
|
|
15
|
Renal function as predictor of mortality in patients after percutaneous transcatheter aortic valve implantation.
|
JACC Cardiovasc Interv
|
2010
|
1.41
|
|
16
|
Balloon post-dilation and valve-in-valve implantation for the reduction of paravalvular leakage with use of the self-expanding CoreValve prosthesis.
|
EuroIntervention
|
2016
|
1.40
|
|
17
|
Redox-sensitive vascular smooth muscle cell proliferation is mediated by GKLF and Id3 in vitro and in vivo.
|
FASEB J
|
2002
|
1.38
|
|
18
|
Aortic regurgitation index defines severity of peri-prosthetic regurgitation and predicts outcome in patients after transcatheter aortic valve implantation.
|
J Am Coll Cardiol
|
2012
|
1.34
|
|
19
|
Improvement of endothelial function by systemic transfusion of vascular progenitor cells.
|
Circ Res
|
2006
|
1.28
|
|
20
|
Running exercise of different duration and intensity: effect on endothelial progenitor cells in healthy subjects.
|
Eur J Cardiovasc Prev Rehabil
|
2005
|
1.21
|
|
21
|
Endothelial-regenerating cells: an expanding universe.
|
Hypertension
|
2010
|
1.20
|
|
22
|
High glucose condition increases NADPH oxidase activity in endothelial microparticles that promote vascular inflammation.
|
Cardiovasc Res
|
2013
|
1.16
|
|
23
|
Endothelial microparticle uptake in target cells is annexin I/phosphatidylserine receptor dependent and prevents apoptosis.
|
Arterioscler Thromb Vasc Biol
|
2012
|
1.16
|
|
24
|
First-in-man use of a novel embolic protection device for patients undergoing transcatheter aortic valve implantation.
|
EuroIntervention
|
2012
|
1.12
|
|
25
|
Circulating progenitor cell count for cardiovascular risk stratification: a pooled analysis.
|
PLoS One
|
2010
|
1.09
|
|
26
|
Development of a risk score for outcome after transcatheter aortic valve implantation.
|
Clin Res Cardiol
|
2014
|
1.04
|
|
27
|
Blood transfusion and the risk of acute kidney injury after transcatheter aortic valve implantation.
|
Circ Cardiovasc Interv
|
2012
|
1.01
|
|
28
|
Tracking of systemically administered mononuclear cells in the ischemic brain by high-field magnetic resonance imaging.
|
Neuroimage
|
2006
|
0.97
|
|
29
|
Angiotensin-II type 1 receptor-mediated Janus kinase 2 activation induces liver fibrosis.
|
Hepatology
|
2014
|
0.96
|
|
30
|
Role of integrin-linked kinase in vascular smooth muscle cells: regulation by statins and angiotensin II.
|
Biochem Biophys Res Commun
|
2006
|
0.93
|
|
31
|
From fat fighter to risk factor: the zigzag trek of leptin.
|
Arterioscler Thromb Vasc Biol
|
2004
|
0.92
|
|
32
|
How should I treat an asymptomatic enlarging giant saphenous vein graft aneurysm?
|
EuroIntervention
|
2014
|
0.92
|
|
33
|
Five-year results of the Multicenter Randomized Controlled Open-Label Study of the CYPHER Sirolimus-Eluting Stent in the Treatment of Diabetic Patients with De Novo Native Coronary Artery Lesions (SCORPIUS) study: a German multicenter investigation on the effectiveness of sirolimus-eluting stents in diabetic patients.
|
Am Heart J
|
2012
|
0.89
|
|
34
|
Monocytic microparticles promote atherogenesis by modulating inflammatory cells in mice.
|
J Cell Mol Med
|
2012
|
0.88
|
|
35
|
Impact of paravalvular leakage on outcome in patients after transcatheter aortic valve implantation.
|
JACC Cardiovasc Interv
|
2012
|
0.88
|
|
36
|
Huge saphenous vein graft aneurysm after coronary artery bypass grafting.
|
EuroIntervention
|
2011
|
0.88
|
|
37
|
The revised EuroSCORE II for the prediction of mortality in patients undergoing transcatheter aortic valve implantation.
|
Clin Res Cardiol
|
2013
|
0.87
|
|
38
|
High-density lipoprotein exerts vasculoprotection via endothelial progenitor cells.
|
J Cell Mol Med
|
2010
|
0.87
|
|
39
|
First in vitro and in vivo results of an anti-human CD133-antibody coated coronary stent in the porcine model.
|
Clin Res Cardiol
|
2013
|
0.86
|
|
40
|
Prevalence, factors associated with, and prognostic effects of preoperative anemia on short- and long-term mortality in patients undergoing transcatheter aortic valve implantation.
|
Circ Cardiovasc Interv
|
2013
|
0.85
|
|
41
|
Decrease of pulmonary hypertension impacts on prognosis after transcatheter aortic valve replacement.
|
EuroIntervention
|
2014
|
0.85
|
|
42
|
Microparticles--messengers of biological information.
|
J Cell Mol Med
|
2010
|
0.84
|
|
43
|
Prognostic value of cerebral injury following transfemoral aortic valve implantation.
|
EuroIntervention
|
2013
|
0.84
|
|
44
|
Twelve-month results of the rapid renal sympathetic denervation for resistant hypertension using the OneShotTM ablation system (RAPID) study.
|
EuroIntervention
|
2015
|
0.83
|
|
45
|
Clinical Trial Updates and Hotline Sessions presented at the European Society of Cardiology Congress 2007: (FINESSE, CARESS, OASIS 5, PRAGUE-8, OPTIMIST, GRACE, STEEPLE, SCAAR, STRATEGY, DANAMI-2, ExTRACT-TIMI-25, ISAR-REACT 2, ACUITY, ALOFT, 3CPO, PROSPECT, EVEREST, COACH, BENEFiT, MERLIN-TIMI 36, SEARCH-MI, ADVANCE, WENBIT, EUROASPIRE I-III, ARISE, getABI, RIO).
|
Clin Res Cardiol
|
2007
|
0.83
|
|
46
|
Transcatheter valve implantation improves central sleep apnoea in severe aortic stenosis.
|
EuroIntervention
|
2013
|
0.81
|
|
47
|
Three-dimensional speckle-tracking analysis of left ventricular function after transcatheter aortic valve implantation.
|
J Am Soc Echocardiogr
|
2012
|
0.81
|
|
48
|
The impact of peripheral arterial disease on early outcome after transcatheter aortic valve implantation: results from the German Transcatheter Aortic Valve Interventions Registry.
|
Am Heart J
|
2012
|
0.81
|
|
49
|
Essential role of bone marrow fibroblast growth factor-2 in the effect of estradiol on reendothelialization and endothelial progenitor cell mobilization.
|
Am J Pathol
|
2006
|
0.81
|
|
50
|
Mobilization of endothelial progenitors by recurrent bacteremias with a periodontal pathogen.
|
PLoS One
|
2013
|
0.80
|
|
51
|
Evaluation and management of paravalvular aortic regurgitation after transcatheter aortic valve replacement.
|
J Am Coll Cardiol
|
2013
|
0.80
|
|
52
|
Personalized cardiac regeneration by stem cells-Hype or hope?
|
EPMA J
|
2011
|
0.80
|
|
53
|
Doppler-based renal resistance index for the detection of acute kidney injury and the non-invasive evaluation of paravalvular aortic regurgitation after transcatheter aortic valve implantation.
|
EuroIntervention
|
2014
|
0.80
|
|
54
|
Combination of angiographic and clinical characteristics for the prediction of clinical outcomes in patients undergoing unprotected left main coronary artery stenting.
|
Clin Res Cardiol
|
2012
|
0.79
|
|
55
|
Combination of angiographic and clinical characteristics for the prediction of clinical outcomes in elderly patients undergoing multivessel PCI.
|
Clin Res Cardiol
|
2013
|
0.79
|
|
56
|
TAVR-associated prosthetic valve infective endocarditis: results of a large, multicenter registry.
|
J Am Coll Cardiol
|
2014
|
0.79
|
|
57
|
Endothelial damage and regeneration: the role of the renin-angiotensin-aldosterone system.
|
Curr Hypertens Rep
|
2011
|
0.79
|
|
58
|
Next-generation transcatheter heart valves: current trials in Europe and the USA.
|
Methodist Debakey Cardiovasc J
|
2012
|
0.79
|
|
59
|
Atorvastatin-induced increase in progenitor cell levels is rather caused by enhanced receptor activator of NF-kappaB ligand (RANKL) cell proliferation than by bone marrow mobilization.
|
J Mol Cell Cardiol
|
2013
|
0.79
|
|
60
|
Use of a balloon-expandable transfemoral sheath in a TAVI cohort with complex access site - a propensity score matched analysis.
|
EuroIntervention
|
2015
|
0.78
|
|
61
|
Darbepoetin improves endothelial function and increases circulating endothelial progenitor cell number in patients with coronary artery disease.
|
Heart
|
2011
|
0.78
|
|
62
|
Endothelial RIG-I activation impairs endothelial function.
|
Biochem Biophys Res Commun
|
2012
|
0.78
|
|
63
|
One-year outcomes in 1,010 unselected patients treated with the PROMUS Element everolimus-eluting stent: the multicentre PROMUS Element European Post-Approval Surveillance Study.
|
EuroIntervention
|
2015
|
0.77
|
|
64
|
Role, Function and Therapeutic Potential of microRNAs in Vascular Aging.
|
Curr Vasc Pharmacol
|
2015
|
0.77
|
|
65
|
The prognostic value of acute and chronic troponin elevation after transcatheter aortic valve implantation.
|
EuroIntervention
|
2016
|
0.77
|
|
66
|
Medtronic CoreValve Evolut valve.
|
EuroIntervention
|
2012
|
0.76
|
|
67
|
Prognostic value of cerebral injury following transfemoral aortic valve implantation.
|
EuroIntervention
|
2012
|
0.76
|
|
68
|
Sex hormones save our skin: the vascular networking of estrogen.
|
Circ Res
|
2009
|
0.76
|
|
69
|
Transcatheter aortic valve implantation: the evidence.
|
Heart
|
2012
|
0.76
|
|
70
|
[Perspectives of regenerative mechanisms in cardiovascular disease spotlighting endothelial progenitor cells].
|
Med Klin (Munich)
|
2009
|
0.75
|
|
71
|
Interventional closure of paravalvular leakage after transcatheter aortic valve implantation.
|
Eur Heart J
|
2012
|
0.75
|
|
72
|
Critical role of nucleotide-binding oligomerization domain-like receptor 3 in vascular repair.
|
Biochem Biophys Res Commun
|
2011
|
0.75
|
|
73
|
Transcatheter aortic valve implantation and closure of the left atrial appendage under cerebral protection.
|
EuroIntervention
|
2012
|
0.75
|
|
74
|
Novel approaches for prevention of stroke related to transcatheter aortic valve implantation.
|
Expert Rev Cardiovasc Ther
|
2013
|
0.75
|
|
75
|
An exceptional case of frame underexpansion with a self-expandable transcatheter heart valve despite predilation.
|
JACC Cardiovasc Interv
|
2012
|
0.75
|
|
76
|
Medtronic CoreValve Evolut R with EnVeo R.
|
EuroIntervention
|
2013
|
0.75
|
|
77
|
Challenges in transcatheter valve treatment: aortic regurgitation after transcatheter aortic valve implantation.
|
EuroIntervention
|
2013
|
0.75
|
|
78
|
First experience with a new balloon-expandable and re-collapsible vascular sheath in transfemoral percutaneous aortic valve replacement.
|
Catheter Cardiovasc Interv
|
2013
|
0.75
|
|
79
|
Right heart transcatheter valve therapies - a review of prostheses for the pulmonary and tricuspid positions.
|
Expert Rev Med Devices
|
2014
|
0.75
|
|
80
|
Provisional Closure of an Iatrogenic Atrial Septal Defect for Shunt Reversal After Transcatheter Treatment of Tricuspid Regurgitation.
|
J Invasive Cardiol
|
2019
|
0.75
|